In a significant public health initiative, the Plateau State Government has treated 311 of 312 reported snakebite cases through its Free Anti-Snake Venom (ASV) programme, demonstrating a proactive approach to a health crisis that disproportionately affects rural communities. Launched in December 2025, the programme has garnered attention for its effectiveness in combating venomous snake bites, a frequent hazard in agricultural areas.
The Director-General of the Plateau State Drugs and Medical Commodities Management Agency, Dr. John D. Gyang, highlighted the programme’s impact, stating, “This initiative not only saves lives but also alleviates the financial burden on families who cannot afford treatment.” The high recovery rate reflects the government's commitment to improving healthcare access and addressing the public health challenges posed by snakebites in the region.
Looking ahead, the success of the ASV programme could serve as a model for other states facing similar health challenges. As Plateau continues to refine its healthcare strategies, the emphasis on accessible treatment options may significantly reduce the incidence of snakebite fatalities and improve overall community health outcomes.